Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM: Correspondence from The New England Journal of Medicine — Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
Comments
Post a Comment